Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality
Year: 2019
Type: article
Abstract: AIMS/HYPOTHESIS: Adults with type 2 diabetes are at high risk of developing cardiovascular disease (CVD). Evidence of the impact of weight loss on incidence of CVD events among adults with diabetes is sparse and conflicting. We assessed weight change in the year following diabetes diagnosis and estimated associations with 10 year incidence of CVD events and all-cause mortality. METHODS: In a cohort analysis among 725 adults with screen-detected diabetes enrolled in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Cambridge trial, we estimated HRs for weight change in the year following diabetes diagnosis and 10 year incidence of CVD (n = 99) and all-cause mortality (n = 95) using Cox proportional hazards regression. We used linear regression to estimate associations between weight loss and CVD risk factors. Models were adjusted for age, sex, baseline BMI, smoking, occupational socioeconomic status, cardio-protective medication use and treatment group. RESULTS: and blood lipids and a lower hazard of CVD at 10 years compared with maintaining weight (HR 0.52 [95% CI 0.32, 0.86]). The associations between weight gain vs weight maintenance and CVD (HR 0.41 [95% CI 0.15, 1.11]) and mortality (HR 1.63 [95% CI 0.83, 3.19]) were less clear. CONCLUSIONS/INTERPRETATION: Among adults with screen-detected diabetes, loss of ≥5% body weight during the year after diagnosis was associated with a lower hazard of CVD events compared with maintaining weight. These results support the hypothesis that moderate weight loss may yield substantial long-term CVD reduction, and may be an achievable target outside of specialist-led behavioural treatment programmes.
Source: Diabetologia
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,390
Funders: Wellcome Trust, National Institute for Health and Care Research, University of Cambridge, University of Southampton, King's College London, Cardiff University, Cambridge University Hospitals, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Medical Research Council, Menzies Centre for Australian Studies, King's College London, University of London, Health Technology Assessment Programme, Programme Grants for Applied Research, NIHR Cambridge Biomedical Research Centre, NIHR Evaluation Trials and Studies Coordinating Centre
Awards: Aetiology of type 2 diabetes and related metabolic disorders, G1262089179, Anglo-Danish-Dutch study of Intensive Treatment of people with Newly diagnosed diabetes in primary care (ADDITION) - effects on cardiovascular events at five years, G2448080532, Epidemiological contribution to primary and secondary prevention of diabetes and obesity, G4532840192, G6514246486, A randomised trial of the cost-effectiveness of a program of screening and intensive multifactorial intervention for Type 2 diabetes in primary care., Reducing the burden of type 2 diabetes: translating epidemiology and behavioural science into preventive action, NIHR Senior Investigator Award, NIHR Senior Investigator Award
OpenAlex ID: W2943997545
